China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill,...
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture ...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a collabo...
The healthcare industry in Asia Pacific (APAC), home to half the world's population, faces a dual reality: immense oppor...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors’ decision...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville,...
Singapore-based Zuellig Pharma, a leading healthcare solutions company in Asia, has expanded its partnership with H...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
At the 2nd International Forum of Pharmaceutical Inspectorates (IFPI), held on November 24–25 at the Marriott Hote...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquart...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Japan's Santen Pharmaceutical and the Singapore Eye Research Institute (SERI) have launched the Santen–SERI Open I...
South Korea-based Samsung Bioepis Co. has announced the launch of OBODENCE™ (60 mg pre-filled syringe) a...
Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enable...
